Front Line Genomics

At Front Line Genomics, we aim to accelerate the advantages of genomics for everyone. Our platform includes a website, a magazine, and the Festivals of Genomics, all designed to assist scientists, healthcare professionals, industry leaders, and government officials. We work with individuals from academia, research institutions, and various sectors to unlock the full promise of genomic medicine.

International

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#635447

United States

#441626

Science and Education/Biology

#1040

Traffic sources

Monthly visitors

Articles

Proteogenomics: Where next?

Jan 8, 2025 | frontlinegenomics.com | Lyndsey Fletcher

Proteogenomics offers new, in-depth insight into biology and life, going beyond the DNA to encompass the entire central dogma. However, key challenges remain in getting proteogenomics-based approaches in clinical trials. Using information from our recent Next Gen Proteomics event, we’ve summarised these challenges and some potential solutions.
The early environment is a really important time window for allowing us to adapt: A conversation with Christopher Murgatroyd

Jan 6, 2025 | frontlinegenomics.com | Lyndsey Fletcher

The Festival of Genomics and Biodata is just around the corner, and we’ve had the opportunity to sit down with some of our expert speakers to get a sneak peek into what they’ll be discussing, and why they think you should come along to the event. In today’s interview, we speak to Christopher Murgatroyd (Professor of Epigenetics, Manchester Metropolitan University) about early life stressors and their impact on health outcomes in later life. Register for the Festival of Genomics and Biodata here.
Standardisation in single-cell: What do the experts say?

Dec 11, 2024 | frontlinegenomics.com | Lyndsey Fletcher

Technical variability can have a significant impact on single-cell experiments, potentially affecting the accuracy and reproducibility of the results. Unlike biological variability, which reflects true differences in gene expression between individual cells, technical variability arises from experimental and processing inconsistencies. In this feature, we explore the impacts of technical variability, and how standardisation might be the way forward.
Week in Brief: Week Ending 6th December

Dec 9, 2024 | frontlinegenomics.com | Lyndsey Fletcher

A new study has shown that language transmission patterns have a genetic component. Language transmission in individuals who learned their first language from their mother or mother’s family may follow maternally inherited genes, showing that both culture and genetics can influence our lives (PNAS). Women who had both their ovaries removed at a young age have unique risk and resilience factors for Alzheimer’s disease, according to a new study.
Week in Brief: Week Ending 29th November

Dec 3, 2024 | frontlinegenomics.com | Lyndsey Fletcher

Scientists have developed an algorithm that can identify cell populations responsible for aggressive tumour growth. Identifying these drivers can help predict patient outcomes and point towards better treatments (Nature Genetics). Several mechanisms that contribute to the progression of Ewing sarcoma have been identified in a recent study. These revelations could lead to potential therapies to counteract aggressive tumour growth (EMBO Reports).
What's the Challenge?

Nov 26, 2024 | frontlinegenomics.com | Lyndsey Fletcher

Mass spectrometry-based proteomics can offer valuable insights into biological processes and disease. This is due to its antibody-free nature and ability to directly measure proteins, its large linear dynamic range and the fact it is multiplexable. So, what’s holding back the use of mass spec in clinical trials?
Week in Brief: Week Ending 22nd November

Nov 25, 2024 | frontlinegenomics.com | Lyndsey Fletcher

Over 40 papers associated with The Human Cell Atlas consortium were published this week. According to the press release, the papers encompass everything from ‘how the placenta and skeleton form, changes during brain maturation, new gut and vascular cell states, lung responses to COVID-19, investigating how genetic variation impacts on disease, and many more.’ The findings have far-reaching implications for research, healthcare and beyond (Human Cell Atlas).
Dementia and the Proteome: Lessons from Next Gen Proteomics

Nov 22, 2024 | frontlinegenomics.com | Lyndsey Fletcher

Did you know that many conditions that originate outside of the brain can influence dementia risk? At our recent FOG Live: Next Gen Proteomics event, Keenan Walker (Investigator & Chief of the Mind Unit, National Institute on Aging (NIA/NIH)) explains why this is the case, Here, we summarise the key takeaways from his talk. According to Keenan’s talk, systemic health conditions and cellular aging processes outside the central nervous system can influence the proteome.
A Conversation with Chris Lord

Nov 19, 2024 | frontlinegenomics.com | Lyndsey Fletcher

The Festival of Genomics and Biodata is just around the corner, and we’ve had the opportunity to sit down with some of our expert speakers to get a sneak peek into what they’ll be discussing, and why they think you should come along to the event. In today’s , we speak to Chris Lord (Institute of Cancer Research) about the importance of pursuing precision medicine strategies, molceular mechanisms underpinning cancer progression and the key moments in his career.
Week in Brief: Week Ending 15th November

Nov 18, 2024 | frontlinegenomics.com | Lyndsey Fletcher

A study has revealed that the gene responsible for Huntington’s disease may also be linked to early brain development and human intelligence (The Annals of Neurology). Some genetic mutations in a gene typically associated with the onset of development disorders may not cause harm, according to a recent study. Instead, some variants may confer protection to some neurological disorders (Genomic Psychiatry).